Hidoc Dr | Medical Learning App for Doctors

Today's Updates

5 Psychiatry Headlines You Missed in September 2026

Published Date: 06 Oct 2026

5 Psychiatry Headlines You Missed in September 2026

Givinostat Data Point to Delayed Loss of Ambulation, Preserved Muscle Tissue in DMD Isabella Ciccone, MPH

Published Date: 06 Oct 2026

An updated open-label extension analysis and new MRI data from the phase 3 EPIDYS trial, presented at the 2026 AANEM Annual Meeting, add to the evidence for givinostat's long-term effects on disease progression.

Nipocalimab’s Safety Profile Slightly Favored Over Other Myasthenia Gravis Therapies, Indirect Comparison Shows Marco Meglio

Published Date: 06 Oct 2026

A new Bayesian network meta-analysis found nipocalimab's serious adverse event rates compared favorably with other gMG therapies, while overall adverse event rates were comparable.

Early Spinal Muscular Atrophy Treatment Tied to Milder Pediatric Phenotype Marco Meglio

Published Date: 06 Oct 2026

New data from a Cure SMA survey showed that children treated with disease-modifying therapy soon after birth walk more often and have fewer comorbidities than those treated later.

NeurologyLive® Brain Games: October 4, 2026 Louie Pasculli

Published Date: 06 Oct 2026

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the history of MDS!

Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis

Published Date: 06 Oct 2026

Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis

Corticosteroid Stewardship in Dermatology is Not Steroid Avoidance, With Adam Friedman, MD Adam Friedman, MD, FAAD

Published Date: 06 Oct 2026

Friedman outlines how dermatologists can track cumulative corticosteroid exposure, identify at-risk patients, and improve patient adherence with handouts.

Patient Perspective on Topical Steroid Withdrawal, With Briana Banos Briana Banos

Published Date: 06 Oct 2026

Topical steroid withdrawal advocate Briana Banos urged clinicians to stay curious and treat patients as experts on their own bodies.

EADV 2026: Telikibart Attains EASI-75 in 70% at Week 16 in Atopic Dermatitis

Published Date: 06 Oct 2026

EADV 2026: Telikibart Attains EASI-75 in 70% at Week 16 in Atopic Dermatitis

Q&A: Dupilumab Improves Quality of Life in Omalizumab-Naive CSU

Published Date: 06 Oct 2026

Q&A: Dupilumab Improves Quality of Life in Omalizumab-Naive CSU

Knowledge Hub

Oncology

Monitoring Delayed Toxicity of Antibody Therapies

Comprehensive review of delayed toxicity monitoring in antibody therapies for clinicians.

Oncology

Personalized Oncolytic Virus Combinations: Current Evidence and Clinical Implications

A comprehensive review of personalized oncolytic virus combinations in oncology, highlighting mechanisms, clinical evidence, and practical guidance.

Oncology

Population Surveillance of Environmental Cancer Risk Clusters

Comprehensive review of population surveillance for environmental cancer risk clusters, with clinical and scientific insights for healthcare professionals.

Oncology

Community Strategies for Improving Cancer Prevention Literacy

Evidence-based review of community strategies to improve cancer prevention literacy for healthcare professionals.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

5 Psychiatry Headlines You Missed in September 2026

Givinostat Data Point to Delayed Loss of Ambulation, Preserved Muscle Tissue in DMD Isabella Ciccone, MPH

Nipocalimab’s Safety Profile Slightly Favored Over Other Myasthenia Gravis Therapies, Indirect Comparison Shows Marco Meglio

Early Spinal Muscular Atrophy Treatment Tied to Milder Pediatric Phenotype Marco Meglio

NeurologyLive® Brain Games: October 4, 2026 Louie Pasculli

Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis

Corticosteroid Stewardship in Dermatology is Not Steroid Avoidance, With Adam Friedman, MD Adam Friedman, MD, FAAD

Patient Perspective on Topical Steroid Withdrawal, With Briana Banos Briana Banos

EADV 2026: Telikibart Attains EASI-75 in 70% at Week 16 in Atopic Dermatitis

Q&A: Dupilumab Improves Quality of Life in Omalizumab-Naive CSU

Knowledge Hub

Monitoring Delayed Toxicity of Antibody Therapies

Personalized Oncolytic Virus Combinations: Current Evidence and Clinical Implications

Population Surveillance of Environmental Cancer Risk Clusters

Community Strategies for Improving Cancer Prevention Literacy

Mechanisms of Tumor Cell Plasticity During Metastatic Spread

Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications

Preventing Treatment-Induced Peripheral Neuropathy in Cancer Care

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

5 Psychiatry Headlines You Missed in September 2026

Givinostat Data Point to Delayed Loss of Ambulation, Preserved Muscle Tissue in DMD Isabella Ciccone, MPH

Nipocalimab’s Safety Profile Slightly Favored Over Other Myasthenia Gravis Therapies, Indirect Comparison Shows Marco Meglio

Early Spinal Muscular Atrophy Treatment Tied to Milder Pediatric Phenotype Marco Meglio

NeurologyLive® Brain Games: October 4, 2026 Louie Pasculli

Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis

Corticosteroid Stewardship in Dermatology is Not Steroid Avoidance, With Adam Friedman, MD Adam Friedman, MD, FAAD

Patient Perspective on Topical Steroid Withdrawal, With Briana Banos Briana Banos

EADV 2026: Telikibart Attains EASI-75 in 70% at Week 16 in Atopic Dermatitis

Q&A: Dupilumab Improves Quality of Life in Omalizumab-Naive CSU

Knowledge Hub

Monitoring Delayed Toxicity of Antibody Therapies

Personalized Oncolytic Virus Combinations: Current Evidence and Clinical Implications

Population Surveillance of Environmental Cancer Risk Clusters

Community Strategies for Improving Cancer Prevention Literacy

Mechanisms of Tumor Cell Plasticity During Metastatic Spread

Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications

Preventing Treatment-Induced Peripheral Neuropathy in Cancer Care

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views